Amplatzer Steerable Delivery Sheath Recall

In July 2023, Abbott recalled the Amplatzer Steerable Delivery Sheath because of an increased risk of air emboli in patients’ bodies during cardiac procedures. The FDA classified the Amplatzer Steerable Delivery Sheath recall as a Class I recall because air emboli may lead to stroke or death.

Last Modified: October 2, 2023
Fact Checked

Editors carefully fact-check all content for accuracy and quality. has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch? has been empowering patients for more than a decade has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.


  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us


"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Why Were Amplatzer Steerable Delivery Sheaths Recalled?

Abbott recalled Amplatzer Steerable Delivery Sheaths because of an increased risk of creating air bubbles, or air emboli, in patients who undergo procedures with this device. Air bubbles in the body can cause blood flow problems, low blood pressure or lack of oxygen. Doctors use the delivery sheaths in patients having heart procedures. 

As of July 2023, Abbott received reports of 26 incidents and 16 injuries. The company is not aware of any deaths or permanent injuries related to the recalled Amplatzer Steerable Delivery Sheaths. According to Abbott’s medical device recall letter sent to medical providers, the incident rate was about 0.77%.

Which ASDS Devices Were Recalled?

As of July 2023, only one ASDS device model was included in the recall. Abbott recalled the ASDS-14F-075 model that was distributed from Oct. 4, 2022, to Feb. 22, 2023.

Recalled ASDS Batch Numbers:
  • 8597228
  • 8598983
  • 8601676
  • 8611443
  • 8619197
  • 8627877
  • 8650955
  • 8663679
  • 8795668
  • 8815423
  • 8824607
  • 8830530
  • 8846835

According to the recall notice, Abbott recalled 672 ASDS devices in the U.S. Two other recalled devices were distributed globally in Slovakia and the Czech Republic for a total of 675 units.

What Are the Risks of Using a Recalled Amplatzer Steerable Delivery Sheath?

The main risk of using a recalled Amplatzer Steerable Delivery Sheath involves the development of air emboli during cardiac procedures. In serious cases, air emboli may lead to stroke, death or other serious injuries. 

People who have cardiac procedures with the recalled device have the highest risk of potential ASDS complications, according to the FDA’s recall notice.

Potential ASDS injuries include:
  • Death
  • Fast or slow heartbeat
  • Low blood oxygen
  • Low blood pressure
  • Stroke
  • Sudden reduction in blood flow to the heart

Because of the risk of serious injuries, the FDA classified this recall as Class I. A Class I recall is the most serious type of recall, indicating the recalled device may cause serious injuries or death.

See if You Qualify for a Lawsuit Our Partners

Our Trusted Legal Partners

Drugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.

simmons hanly conroy law firm logo weitz and luxenberg logo sokolove law firm logo levin papantonio rafferty law firm logo nigh goldenberg raso and vaughn law firm logo morgan & morgan logo the ferraro law firm logo meirowitz & wasserberg law firm logo

What to Do if You Were Affected by the ASDS Recall

If you are a patient who had a procedure with a recalled ASDS device and suffered complications, you can report these incidents to the FDA’s MedWatch Safety Information and Adverse Event Reporting program. You may also call 1-800-332-1088 for instructions on how to mail or fax a report form.

Lawyers are investigating any ASDS defects and are filing Amplatzer Steerable Delivery Sheath lawsuits on behalf of patients injured by the device. You may be able to seek compensation for your injuries or file a wrongful death lawsuit on behalf of a loved one who suffered a fatal injury.

Medical providers should return any unused ASDS devices to Abbott. Contact an Abbott representative for assistance. Abbott recommends using the fixed curve TorqVue 45° x 45° delivery system in place of the ASDS device.

Abbott’s Reaction to the ASDS Recall

Abbott reacted to the recall by sending medical device recall notices to customers in June 2023. The company explained the problems and risks of using the device along with instructions to return unused recalled devices.

The company stressed that this recall issue is specific to the homeostasis valve of the ASDS and does not affect the Amplatzer Amulet Left Atrial Appendage Occluder implant. Instructions for ASDS use indicate that putting the valve in the closed position “minimizes blood loss but does not prevent air ingress,” according to Abbott’s medical device recall letter.

The instructions also provided ways to reduce air entering the device, but the company still received reports of air emboli. This led to Abbott’s decision to recall the device.

Please seek the advice of a medical professional before making health care decisions.